Posts

Showing posts with the label Community

Tails, Trails, and Thrift Stores: Why Our Pal’s Place is the Coolest Animal Rescue on the Block

Image
  Let’s be honest: the world can be a bit chaotic, but animals make it infinitely better. If you love furry faces as much as I do, you’ve probably spent your fair share of time scrolling through adoption photos or dreaming of opening a backyard sanctuary. Well, pack your bags (metaphorically), because today we are taking a digital road trip to Marietta, Georgia to spotlight an organization that is doing animal rescue a little differently: Our Pal’s Place (O.P.P.) . They aren't just your standard "find a dog, match a dog" shelter. They are on a mission to completely change how humans treat animals, combining physical rescue work with a massive dose of community education. Grab a cup of coffee (or tea, or dirt—if you’ve been gardening like me), and let’s dive into why O.P.P. is absolutely crushing the animal welfare game. ๐Ÿพ The Ultimate Underdog Advocates Here is the deal: O.P.P. focuses their rescue efforts on saving orphaned pets from county shelters who are running out ...

FDA Approves First-Ever Disease-Modifying Drug for Newly Diagnosed T1D Patients

Image
  The FDA has approved Tzield (teplizumab) as the first disease-modifying therapy for patients recently diagnosed with Stage 3 type 1 diabetes (T1D) .  As someone passionate about health and wellness, I always keep a close eye on major medical shifts—but this milestone hits incredibly close to home for my family. My own child was diagnosed with Type 1 Diabetes at just 6 years old, so I know firsthand the daily challenges, fears, and endless calculations that come with managing this condition. The FDA has approved Tzield (teplizumab) as the first disease-modifying therapy for patients recently diagnosed with Stage 3 type 1 diabetes (T1D). Previously used to delay the onset of clinical diabetes in at-risk (Stage 2) individuals, Tzield's new indication focuses on preserving remaining insulin-producing beta cells in patients aged 8 to 17 who have just transitioned to Stage 3. This milestone marks a massive shift from managing diabetes symptoms with insulin alone to slowing dow...

Check Your Shelves: FDA Expands Pet Food Recall Over Dangerous Vitamin Deficiencies

The U.S. Food and Drug Administration (FDA) has announced an expanded voluntary recall of select pet food products due to potentially dangerous vitamin deficiencies . On June 8, 2026, Utah-based manufacturer Go Raw LLC added an additional lot of its Steve’s Real Food Chicken Recipe Freeze-Dried pet food to a prior recall after discovering the food may contain critically low levels of thiamine (Vitamin B1) . This expansion builds upon initial recalls from February 2026 that affected chicken-based Quest Cat Food products. Because a prolonged lack of thiamine can trigger severe, life-threatening health issues, pet parents nationwide are being urged to check their pantries immediately. What Products are Affected? The newest addition to the recall list involves freeze-dried food formulated for both dogs and cats. The manufacturer notes that the affected inventory has largely cleared distribution channels, but bags may still exist in consumer homes. According to the FDA Safety Announcemen...